• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑梗死的实验模型与治疗试验

Experimental models and treatment trials for cerebral infarction.

作者信息

Isozumi K, Izumi Y

机构信息

Department of Neurology, Ashikaga Red Cross Hospital, Tochigi-ken, Japan.

出版信息

Tokai J Exp Clin Med. 1998 Jun;23(3):103-17.

PMID:9972537
Abstract

Recent progress in both experimental and clinical studies of cerebral infarction is outlined, and research on delayed neuronal death and ischemic penumbra is described. Development of animal models to study clinical pathophysiology is reviewed, and our focal cerebral ischemia model which has been used for many years is introduced. With elucidation of the pathophysiology of cerebral ischemia, various pharmaceutical agents have appeared recently in the clinical setting and our experimental trials on the treatment of cerebral ischemia are also introduced. From the clinical aspect, practical methods of treatment including antiplatelet therapy are explained. Cerebrovascular dementia and its prevention are also described.

摘要

概述了脑梗死实验研究和临床研究的最新进展,并描述了关于迟发性神经元死亡和缺血半暗带的研究。回顾了用于研究临床病理生理学的动物模型的发展,并介绍了我们多年来使用的局灶性脑缺血模型。随着脑缺血病理生理学的阐明,各种药物制剂最近出现在临床环境中,同时也介绍了我们关于脑缺血治疗的实验性试验。从临床角度解释了包括抗血小板治疗在内的实际治疗方法。还描述了脑血管性痴呆及其预防。

相似文献

1
Experimental models and treatment trials for cerebral infarction.脑梗死的实验模型与治疗试验
Tokai J Exp Clin Med. 1998 Jun;23(3):103-17.
2
Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats.利多卡因可减轻大鼠短暂性局灶性脑缺血后缺血半暗带的细胞凋亡并减小梗死灶体积。
Neuroscience. 2004;125(3):691-701. doi: 10.1016/j.neuroscience.2004.02.034.
3
[Gene therapy for cerebral infarction (cerebral ischemia)].[脑梗死(脑缺血)的基因治疗]
No To Shinkei. 2002 Mar;54(3):213-9.
4
[In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].[脑缺血的体内研究:神经保护剂在动物研究中的应用]
Therapie. 2002 Nov-Dec;57(6):554-63.
5
[Current status and controversies on the management of cerebral main trunk occlusion].
Nihon Rinsho. 2001 May;59(5):1005-12.
6
A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.一种选择性内皮素ET(A)受体拮抗剂SB 234551可改善大鼠永久性局灶性脑缺血后的脑灌注。
Brain Res. 2005 May 31;1045(1-2):150-6. doi: 10.1016/j.brainres.2005.03.025. Epub 2005 Apr 15.
7
[Experimental techniques for developing new drugs acting on dementia (9)--Brain ischemia models].
Nihon Shinkei Seishin Yakurigaku Zasshi. 1995 Apr;15(2):103-14.
8
[Experimental models of cerebral ischemia].[脑缺血的实验模型]
Rev Neurol. 2008;47(8):414-26.
9
From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.从药理前景到对照临床试验,再到荟萃分析,最后回归:尼莫地平在脑血管疾病中的应用案例
Clin Trials Metaanal. 1994 Apr;29(1):57-79.
10
A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.对急性中风的NXY-059神经保护研究的批判性评估:需要在中风动物模型中对神经保护剂进行更严格的测试。
Exp Neurol. 2007 May;205(1):20-5. doi: 10.1016/j.expneurol.2007.03.003. Epub 2007 Mar 12.